A comprehensive study of the direct and indirect costs of adult asthma
Miriam G. Cisternas(Data Management Services (United States)), Edward H. Yelin(Unknown), Irene H. Yen(Fine Arts Museums of San Francisco), Patricia Katz(University of California, San Francisco), Paul D. Blanc(University of California, San Francisco), Gillian Earnest(Pulmonary and Critical Care Associates), Stephen Shiboski(Fine Arts Museums of San Francisco), Mark D. Eisner(Royal Victoria Infirmary)
Cited by 280
Related Papers
Lebrikizumab Treatment in Adults with Asthma
|New England Journal of Medicine|2011|1.5k
An Official American Thoracic Society Public Policy Statement: Novel Risk Factors and the Global Burden of Chronic Obstructive Pulmonary Disease
|American Journal of Respiratory and Critical Care Medicine|2010|986
Pulmonary Dead-Space Fraction as a Risk Factor for Death in the Acute Respiratory Distress Syndrome
|New England Journal of Medicine|2002|898
Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury*
|Critical Care Medicine|2005|729
Omalizumab in Severe Allergic Asthma Inadequately Controlled With Standard Therapy
|Annals of Internal Medicine|2011|550